Skip to main content

Heterogenous Populations of Tissue-Resident CD8 T Cells Are Generated in Response to Infection and Malignancy.

Citation
Milner, J., et al. “Heterogenous Populations Of Tissue-Resident Cd8 T Cells Are Generated In Response To Infection And Malignancy.”. Immunity, pp. 808-824.e7.
Center UCSD-UCLA
Author Justin Milner, Clara Toma, Zhaoren He, Nadia S Kurd, Quynh P Nguyen, Bryan McDonald, Lauren Quezada, Christella E Widjaja, Deborah A Witherden, John T Crowl, Laura A Shaw, Gene W Yeo, John T Chang, Kyla D Omilusik, Ananda W Goldrath
Keywords T cell, memory T cell, single-cell RNA-sequencing, tissue-resident memory T cells, tumor immunity
Abstract

Tissue-resident memory CD8 T cells (Trm) provide host protection through continuous surveillance of non-lymphoid tissues. Using single-cell RNA-sequencing (scRNA-seq) and genetic reporter mice, we identified discrete lineages of intestinal antigen-specific CD8 T cells, including a Blimp1Id3 tissue-resident effector cell population most prominent in the early phase of acute viral and bacterial infections and a molecularly distinct Blimp1Id3 tissue-resident memory population that subsequently accumulated at later infection time points. These Trm populations exhibited distinct cytokine production, secondary memory potential, and transcriptional programs including differential roles for transcriptional regulators Blimp1, T-bet, Id2, and Id3 in supporting and maintaining intestinal Trm. Extending our analysis to malignant tissue, we also identified discrete populations of effector-like and memory-like CD8 T cell populations with tissue-resident gene-expression signatures that shared features of terminally exhausted and progenitor-exhausted T cells, respectively. Our findings provide insight into the development and functional heterogeneity of Trm cells, which has implications for enhancing vaccination and immunotherapy approaches.

Year of Publication
2020
Journal
Immunity
Volume
52
Issue
5
Number of Pages
808-824.e7
Date Published
12/2020
ISSN Number
1097-4180
DOI
10.1016/j.immuni.2020.04.007
Alternate Journal
Immunity
PMID
32433949
Download citation